Effect of liposome-encapsulated clodronate pretreatment on synthetic vector-mediated gene expression in mice
- 1 March 1999
- journal article
- Published by Springer Nature in Gene Therapy
- Vol. 6 (3) , 448-453
- https://doi.org/10.1038/sj.gt.3300826
Abstract
At the forefront of medicine, Gene Therapy brings you the latest research into genetic and cell-based technologies to treat disease. It also publishes Progress & Prospects reviews and News and Commentary articles, which highlight the cutting edge of the field.Keywords
This publication has 34 references indexed in Scilit:
- Effects of Complement Depletion on the Pharmacokinetics and Gene Delivery Mediated by Cationic Lipid–DNA ComplexesHuman Gene Therapy, 1998
- Effect of serum components on the physico-chemical properties of cationic lipid/oligonucleotide complexes and on their interactions with cellsBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1998
- Role of Alveolar Macrophages in Rapid Elimination of Adenovirus Vectors Administered to the Epithelial Surface of the Respiratory TractHuman Gene Therapy, 1997
- Delivery of Polynucleotides with Polyamine Lipids and PolymersNucleosides and Nucleotides, 1997
- Improved DNA: liposome complexes for increased systemic delivery and gene expressionNature Biotechnology, 1997
- Factors influencing the efficiency of cationic liposome-mediated intravenous gene deliveryNature Biotechnology, 1997
- Activation of the Complement System by Synthetic DNA Complexes: A Potential Barrier for Intravenous Gene DeliveryHuman Gene Therapy, 1996
- ClodronateDrugs, 1994
- Structure and Expression of 3‐Hydroxy‐3‐methylglutaryl Coenzyme A ReductaseaAnnals of the New York Academy of Sciences, 1986
- F4/80, a monoclonal antibody directed specifically against the mouse macrophageEuropean Journal of Immunology, 1981